AzTrials
AzTrials

Knee Osteoarthritis (OA)AMB-OKNCT07481461

Altered Joint Mechanics and Biological Response in Osteoarthritic Knees.

A study testing Photon counting CT scanning (PCCT scanning), Magnetic resonance imaging (MRI scanning) and Gait analysis in people with Knee Osteoarthritis (OA), run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Osteoarthritis (OA) stands out as the most prevalent joint disease. It manifests as a progressive degradation of articular cartilage, new bone growth and often synovial tissue proliferation, resulting in pain and compromised joint functionality, ultimately leading to disability. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Knee Osteoarthritis (OA)
What is being tested?
Photon counting CT scanning (PCCT scanning), Magnetic resonance imaging (MRI scanning) and Gait analysis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteBelgium
Study dates
12 May 2026to Apr 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures.
  • Chronic symptoms of (early) knee OA.
  • Misalignment of the lower limb and scheduled for HTO surgery (regardless of the HTO technique used (lateral or medial, closing or opening wedge)) or brace treatment.
  • Follow-up at UZ Leuven.

Who cannot join

  • Acute OA symptoms onset (previous knee injury)
  • Pregnant women
  • MRI checklist incomplete or failed
  • BMI > 30
  • Impaired vision or neurological condition that affect coordination and balance
  • Age <18 (no minors will be included in the study)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Belgium1 site, 1 recruiting
  • Universitaire Ziekenhuizen KU Leuven

    Leuven, Vlaams-Brabant, 3000

    Harry van Lenthe, Prof. Ir., +32 16 32 25 95, harry.vanlenthe@kuleuven.be

    Anna Tarasiuk, +32 16 33 88 18, orthopedie.research@uzleuven.be

    Recruiting

Other trials in Belgium

About this study

Official title: Altered Joint Mechanics and Biological Response in Osteoarthritic Knees. A Study in Patients Undergoing Corrective Treatment for Knee Misalignment.

Osteoarthritis (OA) stands out as the most prevalent joint disease. It manifests as a progressive degradation of articular cartilage, new bone growth and often synovial tissue proliferation, resulting in pain and compromised joint functionality, ultimately leading to disability. Misalignment of the lower limb (varus or valgus knees) are recognised as a risk factor for osteoarthritis onset and progression. High tibial osteotomy (HTO) is a surgical technique that allows to shift the load from the affected area to other areas with intact cartilage. Similarly to HTO, braces realign the lower limb, without the need for surgical intervention. These corrective treatments are recommended for the youngest group of patients as it allows them to stay active, as opposed to Total Knee Replacement (TKR). Until today, the effects of braces and HTO on the subchondral bone microstructure and cartilage are not well understood. Investigating these aspects to better understand treatment failures is becoming more and more crucial because global prevalence of knee OA is expected to increase with the ageing of populations.

Read the detailed description

Osteoarthritis (OA) stands out as the most prevalent joint disease. It manifests as a progressive degradation of articular cartilage, new bone growth and often synovial tissue proliferation, resulting in pain and compromised joint functionality, ultimately leading to disability. In 83% of OA patients the knee is affected limiting people from engaging in physical activities, which paves the way for the onset of cardiovascular diseases, obesity, and diabetes. Misalignment of the lower limb (varus or valgus knees) are recognised as a risk factor for osteoarthritis onset and progression. These misalignments of the lower limbs substantially influence the load distribution across the articular surface of the knee joint, and the load imbalance causes the most loaded compartment to wear out earlier. High tibial osteotomy (HTO) is a surgical technique that allows to shift the load from the affected area to other areas with intact cartilage. Similarly to HTO, braces realign the lower limb, without the need for surgical intervention. These corrective treatments are recommended for the youngest group of patients as it allows them to stay active, as opposed to Total Knee Replacement (TKR). However, long-term survivorship of HTO ranges from 40% to 85% and evidence of long-term efficacy of braces is limited. The specific reasons for failure are not well understood, but are probably linked to improper correction, as overcorrection can lead to instability while undercorrection may fail to alleviate symptoms, and no consensus on the optimal amount exist in literature. Until today, the effects of braces and HTO on the subchondral bone microstructure and cartilage are not well understood. Investigating these aspects to better understand treatment failures is becoming more and more crucial because global prevalence of knee OA is expected to increase with the ageing of populations.

Bone remodelling occurs as a consequence of the major change in loading condition, caused by the treatments, but the time frame and the extent to which this happens is unknown. Bone quality is typically evaluated by means of dual-energy X-ray absorptiometry (DXA), which is able to detect 2D changes in bone mineral density, but not suitable to measure regional differences in bone microstructure. High resolution pheripheral quantitative CT (HR-pQCT) is a widespread imaging technique in research context. It allows for 3D measurements and it was proven that it can accurately quantify bone remodelling at the wrist. However, HR-pQCT has a low clinical applicability, due to long scanning time and small field of view, that does not allow imaging of central sites, such as the knee. Photon Counting CT (PCCT) is one of the latest advancements in CT technique, with resolution comparable to HR-pQCT but higher clinical applicability. It was shown that PCCT is suitable to detect bone turnover in the same way as HR-pQCT, allowing for direct characterization of the microstructure at the knee.

Despite extensive in vitro and in vivo research, it remains unclear how the changes in cartilage composition and structure that occur during cartilage degeneration, interact. An in silico model to investigate the causal mechanisms by which the local mechanical environment of injured cartilage drives cartilage degeneration has been developed. The model predictions showed good agreement with previous experimental observations, however a more extensive validation with in vivo data would allow to investigate more physiological conditions.

Being tested
Photon counting CT scanning (PCCT scanning), Magnetic resonance imaging (MRI scanning), Gait analysis
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Photon counting CT scanning (PCCT scanning)Diagnostic test

    Photon Counting CT (PCCT) is a novel imaging technique that allows for in vivo high-resolution imaging of the bone microstructure. It has a large field of view and short scanning time compared to the current gold standard for bone microstructural quantification, High Resolution-peripheral CT (HR-pQCT). PCCT scans are performed at pre-treatment visit, 6 months, 12 months and 24 months post-treatment.

  • Magnetic resonance imaging (MRI scanning)Diagnostic test

    Cartilage is typically imaged with MRI for its high content of water. Different MRI sequences allow to quantify anatomical aspects such as cartilage volume and thickness, but also its contents (proteoglycans and collagen). MRI scans are performed at pre-treatment visit, 12 months and 24 months post-treatment.

  • Gait analysisDiagnostic test

    The load shift after limb realignment will also be measured. Gait analysis (combined with musculoskeletal modelling) will be used to measure joint contact forces and knee joint geometry will be derived from the PCCT and MRI scans. Forces and geometry will be given as input to a Finite Element (FE) model of the knee joint, computing stresses and strains distribution on bone and cartilage. The gait analysis will be performed pre-treatment and 12 months post-treatment.

Study groups in NCT07481461
Study groupRoleWhat they receive
High tibial osteotomyExperimentalHigh tibial osteotomy (HTO) is a surgical technique that allows to shift the load from the affected area to other areas with intact cartilage. This study aimes to include 10 patients receiveing HTO surgery.
Receives: Diagnostic Test: Photon counting CT scanning (PCCT scanning); Diagnostic Test: Magnetic resonance imaging (MRI scanning); Diagnostic Test: Gait analysis
Braces therapyExperimentalBraces realign the lower limb, this corrective treatments occures without the need for surgical intervention. This study aimes to include 20 patients in this treatment arm.
Receives: Diagnostic Test: Photon counting CT scanning (PCCT scanning); Diagnostic Test: Magnetic resonance imaging (MRI scanning); Diagnostic Test: Gait analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone microstructure quantification

    Trabecular morphology will be described with the bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp) and trabecular number (Tb.N).

    Measured: From enrollment to the end of study at 24 months

  2. Mechanical properties in osteoarthritic knees

    A PCCT-based finite element (FE) model will be built to estimate bone strength, stiffness and apparent modulus by simulating an axial compression.

    Measured: From enrollment to the end of study at 24 months

  3. Load shift quantification

    An FE model, simulating forces acting in the knee joint during physiological walking will be built, deriving such forces from gait analysis.

    Measured: From enrollment to the end of study at 24 months

Secondary outcomes (2)
  1. Proteoglycans quantification

    As content of cartilage, proteoglycans will be quantified using a specific MRI sequence at pre-treatment and 12 and 24 months post-treatment. These measurements will be compared with the in silico models prediction through an agreement analysis.

    Measured: From enrollment to the end of study at 24 months

  2. Collagen quantification

    As content of cartilage, collagen will be quantified using a specific MRI sequence at pre-treatment and 12 and 24 months post-treatment. These measurements will be compared with the in silico models prediction through an agreement analysis.

    Measured: From enrollment to the end of study at 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2026
  2. Study start12 May 2026
  3. Primary completionApr 2030 (estimated)
  4. Study completionApr 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The study is designed as a prospective interventional study without IMP. There will be no randomisation as the patients will undergo to the treatment (High tibial osteotomy (HTO) or braces) prescribed to them independently from the study. Patients will be recruited after the treatment has already been recommended by their ortopaedic surgeon, independently from the study purposes, and accepted by the patient. For this study we aim at enrolling 30 patients: 10 receiving HTO surgery and 20 braces therapy.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07481461
Sponsor's protocol ID
S70583
Acronym
AMB-OK
Status last verified
Mar 2026
First submitted
13 Mar 2026
Last updated
10 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Photon counting CT scanning (PCCT scanning), Magnetic resonance imaging (MRI scanning) and Gait analysis in people with Knee Osteoarthritis (OA), run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Harry van Lenthe, Prof. Ir. (+32 16 32 25 95, harry.vanlenthe@kuleuven.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone microstructure quantification (time frame: From enrollment to the end of study at 24 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in